How PBMs are Addressing Rising Healthcare Costs
Strategies for Small and Emerging Manufacturers’ Engagement with PBMs
IRA Drug Provision: What’s Ahead
Managing Medical Benefit Drugs in the Commercial and Medicare Markets
The Current State of the 340B Program
PCMA Chairman of the Board Keynote Address
Health Equity and Pharmaceutical Care
Drug Development Pipeline: Innovation Patient Care, and Cost Management
Tracking New Realities Brought on in 2020
PCMA Diversity & Inclusion Initiative Event
